Callidus Biopharma
Drug discovery company developing enzyme replacement therapies for lysosomal storage disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD28—43m (Dealroom.co estimates May 2013.)
Doylestown Township Pennsylvania (HQ)
Authorizing premium user...